Lawmakers Demand Answers Over Heparin

Law360, New York (February 21, 2008, 12:00 AM EST) -- A pair of U.S. congressmen is looking for answers from the chief executive of Baxter International, hoping to get to the bottom of the growing controversy surrounding the blood-thinning drug heparin that has recently been tied to four deaths and hundreds of adverse reactions.

On Thursday, Reps. John D. Dingell and Bart Stupak, both Michigan Democrats, sent a letter to Baxter CEO Robert Parkinson asking for further information about a Wall Street Journal report that the U.S. Food and Drug Administration failed to inspect a Chinese...
To view the full article, register now.